《業績》巴郡(BRK.A.US)季度經營溢利跌4% 連續11個季度淨沽售股票
「股神」巴菲特投資旗艦巴郡(BRK.A.US)公布第二季業績。季度純利按年跌59%至123.7億美元,每股A股季度純利8,601美元。季度經營溢利按年跌4%至111.6億美元,其中美元下跌的匯兌虧損8.77億美元。
公司就其持有27.4%卡夫亨氏(KHC.US)股份減值37.6億美元。卡夫亨氏宣布考慮策略性選項,包括分拆。公司2019年就卡夫亨氏減值30億美元。公司連續11個季度淨沽售股票,手持現金3,441億美元。公司自去年5月至上月中未曾回購股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.